Oxidative stress can trigger and even aggravate Alzheimer's disease (AD). Glutathione peroxidase (GPX) can regulate oxidative stress by controlling the accumulation of hydrogen peroxide.
Objective
This study aimed to evaluate the GPX activity in patients with AD through a systematic review and meta-analysis.
Methods
Following the PRISMA guidelines, data were retrieved from four electronic databases, including those containing cohort and case-control studies, published up to December 2024. Statistical analyses were conducted using RevMan, and risk of bias was evaluated with the Newcastle-Ottawa Scale.
Results
A total of 1999 scientific papers were collected, and 30 papers were included in this systematic review; 20 were included in the meta-analysis. GPX activity was measured in different tissues, such as erythrocytes, plasma, and postmortem brain. The analyses showed that erythrocytes and plasma GPX activity in most studies were inhibited in AD patients compared to healthy controls.
Conclusions
The analyses showed that GPX activity was decreased in AD patients compared to healthy controls in most of the included studies. More detailed research is needed to better assess the effects of GPX activity on AD-associated cognitive impairment and oxidative stress.
CardosoBROngTPJacob-FilhoW, et al.Glutathione peroxidase 1 Pro198Leu polymorphism in Brazilian Alzheimer's disease patients: relations to the enzyme activity and to selenium status. J Nutrigenet Nutrigenomics2012; 5: 72–80.
2.
OliveiraCSPiccoliBCNogaraPA, et al.Selenium neuroprotection in neurodegenerative disorders. In: KostrzewaRM (eds) Handbook of neurotoxicity. 2nd ed. Cham: Springer, 2021, pp.2489–2523.
3.
DubeySDubeyMJGhoshR, et al.Behavioral and psychological symptoms in neurodegenerative dementias: harbinger, follower, or constant collateral?Egypt J Neurol Psychiatr Neurosurg2022; 58: 102.
4.
TanziRE. The genetics of Alzheimer disease. Cold Spring Harb Perspect Med2012; 2: a006296.
5.
Ionescu-TuckerACotmanCW. Emerging roles of oxidative stress in brain aging and Alzheimer's disease. Neurobiol Aging2021; 107: 86–95.
6.
LeeKHChaMLeeBH. Neuroprotective effect of antioxidants in the brain. Int J Mol Sci2020; 21: 7152.
7.
IratoPSantovitoG. Enzymatic and non-enzymatic molecules with antioxidant function. Antioxidants2021; 10: 579.
8.
PeiJPanXWeiG, et al.Research progress of glutathione peroxidase family (GPX) in redoxidation. Front Pharmacol2023; 14: 1147414.
9.
OlufunmilayoEOGerke-DuncanMBHolsingerD. Oxidative stress and antioxidants in neurodegenerative disorders. Antioxidants2023; 12: 517.
10.
ZarroukAHammoudaSGhzaielI, et al.Association between oxidative stress and altered cholesterol metabolism in Alzheimer's disease patients. Curr Alzheimer Res2020; 17: 823–834.
11.
TorresLLQuaglioNBde SouzaGT, et al.Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis2011; 26: 59–68.
12.
PereiraMESouzaJVGaliciolliMEA, et al.Effects of selenium supplementation in patients with mild cognitive impairment or Alzheimer's disease: a systematic review and meta-analysis. Nutrients2022; 14: 3205.
13.
PageMJMcKenzieJEBossuytPM, et al.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br Med J2021; 372: n71.
14.
Alarcon-GilMTToroSOBaena-CaldasGP. The evidence-based medicine PICO strategy applied to dentistry using MeSH, Emtree and DeCS. Rev Fac Odontol Univ Antioq2019; 31: 91–101.
15.
SterneJAHernánMAReevesBC, et al.ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. Br Med J2016; 355: i4919.
AnnerénGGardnerALundinT. Increased glutathione peroxidase activity in erythrocytes in patients with Alzheimer's disease/senile dementia of Alzheimer's type. Acta Neurol Scand1986; 73: 586–589.
18.
BalmușIMStrungaruSACiobicaA, et al.Preliminary data on the interaction between some biometals and oxidative stress status in mild cognitive impairment and Alzheimer's disease patients. Oxid Med Cell Longev2017; 2017: 7156928.
19.
Bourdel-MarchassonIDelmas-BeauvieuxMCPeuchantE, et al.Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing2001; 30: 235–241.
20.
ChenLRichardsonJSCaldwellJE, et al.Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer's disease and from nondemented controls. Int J Neurosci1994; 75: 83–90.
21.
GarletQIHaskelMVLPereiraRP, et al.Delta-Aminolevulinate dehydratase and glutathione peroxidase activity in Alzheimer's disease: a case-control study. EXCLI J2019; 18: 866–875.
22.
GiavarottiLSimonKAAzzalisLA, et al.Mild systemic oxidative stress in the subclinical stage of Alzheimer's disease. Oxid Med Cell Longev2013; 2013: 609019.
23.
HaynMKremserKSingewaldN, et al.Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in down's syndrome and Alzheimer's disease. Life Sci1996; 59: 537–544.
24.
JeandelCNicolasMBDuboisF, et al.Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology1989; 35: 275–282.
25.
KharraziHVaisi-RayganiARahimiZ, et al.Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease. Clin Biochem2008; 41: 932–936.
26.
KrishnanSRaniP. Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease. Biol Trace Elem Res2014; 158: 158–165.
27.
LovellMAEhmannWDButlerSM, et al.Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology1995; 45: 1594–1601.
28.
MarcusDLThomasCRodriguezC, et al.Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol1998; 150: 40–44.
29.
Martín-AragónSBermejo-BescósPBenedíJ, et al.Metalloproteinase's activity and oxidative stress in mild cognitive impairment and Alzheimer's disease. Neurochem Res2009; 34: 373–378.
30.
NieYChuCQinQ, et al.Lipid metabolism and oxidative stress in patients with Alzheimer's disease and amnestic mild cognitive impairment. Brain Pathol2024; 34: 13202.
31.
De TodaIMMiguélezLVidaC, et al.Altered redox state in whole blood cells from patients with mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis2019; 71: 153–163.
32.
PalmerAM. The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease. J Neural Transm1999; 106: 317–328.
33.
PerrinRBriançonSJeandelC, et al.Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease: a case-control study. Gerontology1990; 36: 306–313.
34.
PuertasMCMartínez-MartosJMCoboMP, et al.Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia. Exp Gerontol2012; 47: 625–630.
35.
RinaldiPPolidoriMCMetastasioA, et al.Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol Aging2003; 24: 915–919.
36.
Rubio-PerezJMAlbaladejoMDZafrillaP, et al.Effects of an antioxidant beverage on biomarkers of oxidative stress in Alzheimer's patients. Eur J Nutr2016; 55: 2105–2116.
37.
SchuesselKLeutnerSCairnsNJ, et al.Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer's disease brain. J Neural Transm2004; 111: 1167–1182.
38.
SerraJADomínguezROMarschoffER, et al.Systemic oxidative stress associated with the neurological diseases of aging. Neurochem Res2009; 34: 2122–2132.
39.
SulkavaRNordbergURErkinjunttiT, et al.Erythrocyte glutathione peroxidase and superoxide dismutase in Alzheimer's disease and other dementias. Acta Neurol Scand1986; 73: 487–489.
40.
VinothkumarGKedharnathCKrishnakumarS, et al.Abnormal amyloid β42 expression and increased oxidative stress in plasma of CKD patients with cognitive dysfunction: a small-scale case-control study comparison with Alzheimer's disease. BBA Clin2017; 8: 20–27.
41.
VuralHDemirinHKaraY, et al.Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. J Trace Elem Med Biol2010; 24: 169–173.
42.
YadavJVermaAKGargRK, et al.Sialic acid associated with oxidative stress and total antioxidant capacity (TAC) expression level as a predictive indicator in moderate to severe Alzheimer's disease. Exp Gerontol2020; 141: 111092.
43.
YoussefPChamiBLimJ, et al.Evidence supporting oxidative stress in a moderately affected area of the brain in Alzheimer's disease. Sci Rep2018; 8: 11553.
44.
PagliaDEValentineWN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med1967; 70: 158–169.
45.
LawrenceRABurkRF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun1976; 71: 952–958.
46.
FlohéLGünzlerWA. Assays of glutathione peroxidase. Methods Enzymol1984; 105: 114–121.
47.
MillsGC. The purification and properties of glutathione peroxidase of erythrocytes. J Biol Chem1959; 234: 502–506.
48.
EllerbyLMBredesenDE. Measurement of cellular oxidation, reactive oxygen species, and antioxidant enzymes during apoptosis. Methods Enzymol2000; 322: 413–421.
HassanWOliveiraCSNoreenH, et al.Organoselenium compounds as potential neuroprotective therapeutic agents. Curr Org Chem2016; 20: 218–231.
51.
ChenLHambrightWSNaR, et al.Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis. J Biol Chem2015; 290: 28097–28106.
52.
HambrightWSFonsecaRSChenL, et al.Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox Biol2017; 12: 8–17.
53.
PanyardDJReusLMAliM, et al.Post-GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3. Alzheimers Dement2024; 20: 5044–5053.
54.
LiFHongXWangH, et al.Association of dietary selenium intake with type 2 diabetes in middle-aged and older adults in China. Nutrients2024; 16: 2367.
55.
YimSHClishCBGladyshevVN. Selenium deficiency is associated with pro-longevity mechanisms. Cell Rep2019; 27: 2785–2797.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
